PATENT CLAIM ANALYSIS

Application Number: 16211684
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "093400"]

Abstract:
The present disclosure provides methods and treatment regimens for treating ulcerative colitis in a subject in need thereof. In particular, the methods described herein comprise treating a subject in need thereof with a treatment regimen comprising the administration of a pharmaceutical composition comprising live non-pathogenic fecal bacteria for at least 8 weeks and at least three times per week. In an aspect, the subject in need thereof exhibits a Mayo endoscopy score of 3 or lower. In some aspects, the subject in need thereof has no concomitant corticosteroid use during said method and has no corticosteroid use immediately prior to commencing said method.

Claim (Index 28):
The method of  claim 22 , wherein the viable non-pathogenic fecal bacteria comprise cultured bacteria.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.64179
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15791868', '15155628', '15594319', '15626880', '15594087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7071126389493566
- 35 USC 102 Novelty (BERT): 0.6922228598416913
- Combined Prediction Score: 0.7056236610385901
- Mean Citation Score: 367.685458
- Max Citation Score: 668.3216
- Similarity Product: 583.4668426383972

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test